The mushroom supplement market in the UK has experienced remarkable growth in recent years, evolving from a niche segment to a mainstream category. This expansio...

Post-market regulations have grown significantly more complex over time. As pharmaceutical products reach broader and more diverse populations, the risk of off-l...

Alzheimer’s disease (AD) represents a growing public health concern. While earlier estimates placed global dementia prevalence at around 50 million people, more ...

Neurological conditions have emerged as the leading global cause of illness and disability, impacting more than 3 billion people.¹ Among these, neurodegenerative...

Neuromodulation is an approach that involves the use of devices to normalise or modulate nerve activity through the targeted delivery of electrical stimuli. Elec...

The biopharmaceutical industry is continually seeking innovative solutions that can improve drug delivery, strengthen patient compliance, and optimise therapeuti...

It’s understandable that regulators’ extensive demands and internal budget pressures have rendered pharmacovigilance primarily a compliance and risk management a...

Innovators in pharma/biopharma seek to implement systems that support the discovery, development, and commercial launch of new products. Of particular interest a...

In the past few decades, nanomedicine has emerged as one of the most promising opportunities in healthcare. By engineering materials at the nanoscale, scientists...

From Drug Complexity to Delivery Strategy As pharmaceutical innovation has accelerated over the past several decades, one reality has remained constant: the m...